Literature DB >> 21120463

The 30-year outcome for patients after myocardial infarction due to coronary artery lesions caused by Kawasaki disease.

Etsuko Tsuda1, Takuya Hirata, Osamu Matsuo, Tadaaki Abe, Hisashi Sugiyama, Osamu Yamada.   

Abstract

This study determined the long-term outcome for patients after myocardial infarction (MI) due to Kawasaki disease (KD). Retrospective analysis was performed for 60 patients who had experienced MI between 1976 and 2007. Their ages at the initial MI ranged from 3 months to 33 years (median, 2 years). The maximum follow-up period after the initial MI was 33 years (median, 16 years). Coronary angiography, left ventriculography, and radioisotope myocardial perfusion imaging (MPI) had been performed for 56 patients more than 2 months after MI when all were in stable condition. The survival rate and ventricular tachycardia (VT)-free survival rate were calculated after the initial MI by the Kaplan-Meier method. Both sustained and nonsustained VT were included. Furthermore, the Cox proportional hazards model was used to analyze which factors influenced the post-MI outcome and which influenced the appearance of VT. The 30-year survival rate was 62.7% (95% confidence interval [CI], 44.6-77.9%), and the 25-year VT-free survival rate after MI was 28.5% (95% CI 15.4-46.5%). The postinfarction left ventricular ejection fraction (LVEF) was related to the outcome in this population (hazard ratio 0.86; 95% CI 0.75-0.95; P = 0.002), whereas the development of VT was related to the post-LVEF and to perfusion abnormalities in MPI (P = 0.0002). The 30-year survival rate after MI was poor for the patients with a low LVEF. With aging, the existence of nonviable myocardium in the infarct area can induce fatal ventricular arrhythmia more than 10 years after the original MI.

Entities:  

Mesh:

Year:  2010        PMID: 21120463     DOI: 10.1007/s00246-010-9838-y

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  16 in total

Review 1.  Coronary artery bypass grafting for coronary artery stenosis caused by Kawasaki disease.

Authors:  Etsuko Tsuda
Journal:  Expert Rev Cardiovasc Ther       Date:  2009-05

2.  Clinical features in adults with coronary arterial lesions caused by presumed Kawasaki disease.

Authors:  Etsuko Tsuda; Mai Matsuo; Hiroaki Naito; Teruo Noguchi; Hiroshi Nonogi; Shigeyuki Echigo
Journal:  Cardiol Young       Date:  2007-02       Impact factor: 1.093

3.  Two adults requiring implantable defibrillators because of ventricular tachycardia and left ventricular dysfunction caused by presumed Kawasaki disease.

Authors:  Syusuke Yagi; Etsuko Tsuda; Wataru Shimizu; Takashi Kurita; Osamu Seguchi; Hiroshi Nonogi; Shiro Kamakura
Journal:  Circ J       Date:  2005-07       Impact factor: 2.993

4.  Mortality among patients with a history of Kawasaki disease: the third look. The Kawasaki Disease Follow-up Group.

Authors:  Y Nakamura; H Yanagawa; H Kato; K Harada; T Kawasaki
Journal:  Acta Paediatr Jpn       Date:  1998-10

5.  Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?

Authors:  Steven J Kernis; Kishore J Harjai; Gregg W Stone; Lorelei L Grines; Judith A Boura; William W O'Neill; Cindy L Grines
Journal:  J Am Coll Cardiol       Date:  2004-05-19       Impact factor: 24.094

6.  Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy.

Authors:  Robert N Doughty; Gillian A Whalley; Helen A Walsh; Greg D Gamble; José López-Sendón; Norman Sharpe
Journal:  Circulation       Date:  2004-01-05       Impact factor: 29.690

7.  National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan.

Authors:  Etsuko Tsuda; Soichiro Kitamura
Journal:  Circulation       Date:  2004-09-14       Impact factor: 29.690

8.  Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases.

Authors:  H Kato; E Ichinose; T Kawasaki
Journal:  J Pediatr       Date:  1986-06       Impact factor: 4.406

9.  Focal mechanisms underlying ventricular tachycardia during prolonged ischemic cardiomyopathy.

Authors:  S M Pogwizd
Journal:  Circulation       Date:  1994-09       Impact factor: 29.690

10.  Epidemiologic features of Kawasaki disease in Japan: results from the nationwide survey in 2005-2006.

Authors:  Yosikazu Nakamura; Mayumi Yashiro; Ritei Uehara; Izumi Oki; Makoto Watanabe; Hiroshi Yanagawa
Journal:  J Epidemiol       Date:  2008-07-18       Impact factor: 3.211

View more
  21 in total

1.  Coronary and intracerebral arterial aneurysms in a young adult with acute coronary syndrome.

Authors:  Eric H Yang; Nikhil Kapoor; Ali Gheissari; Steven Burstein
Journal:  Tex Heart Inst J       Date:  2012

2.  Magnetocardiographic recognition of abnormal depolarization and repolarization in patients with coronary artery lesions caused by Kawasaki disease.

Authors:  Wataru Tamaki; Etsuko Tsuda; Syuji Hashimoto; Tamami Toyomasa; Mikiya Fujieda
Journal:  Heart Vessels       Date:  2019-03-25       Impact factor: 2.037

3.  Evaluating the time-varying risk of hypertension, cardiac events, and mortality following Kawasaki disease diagnosis.

Authors:  Jennifer J Y Lee; Brian M Feldman; Brian W McCrindle; Ping Li; Rae Sm Yeung; Jessica Widdifield
Journal:  Pediatr Res       Date:  2022-08-24       Impact factor: 3.953

4.  Cardiovascular Outcomes During Index Hospitalization in Children with Kawasaki Disease in Ontario, Canada.

Authors:  Cal Robinson; Megan Schlorff; Rahul Chanchlani; Anastasia Gayowsky; Elizabeth Darling; Tapas Mondal; Hsien Seow; Michelle Batthish
Journal:  Pediatr Cardiol       Date:  2022-09-08       Impact factor: 1.838

5.  Importance of evaluation of the right coronary artery by two-dimensional echocardiography in patients after Kawasaki disease: a right parasternal approach.

Authors:  Wataru Tamaki; Etsuko Tsuda; Igarashi Takehiro; Norio Tanaka; Mikiya Fujieda
Journal:  Heart Vessels       Date:  2014-02-09       Impact factor: 2.037

6.  Thrombotic risk stratification using computational modeling in patients with coronary artery aneurysms following Kawasaki disease.

Authors:  Dibyendu Sengupta; Andrew M Kahn; Ethan Kung; Mahdi Esmaily Moghadam; Olga Shirinsky; Galina A Lyskina; Jane C Burns; Alison L Marsden
Journal:  Biomech Model Mechanobiol       Date:  2014-04-11

7.  Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.

Authors:  Kevin G Friedman; Kimberly Gauvreau; Akiko Hamaoka-Okamoto; Alexander Tang; Erika Berry; Adriana H Tremoulet; Vidya S Mahavadi; Annette Baker; Sarah D deFerranti; David R Fulton; Jane C Burns; Jane W Newburger
Journal:  J Am Heart Assoc       Date:  2016-09-15       Impact factor: 5.501

8.  Imaging-based biomarkers: characterization of post-kawasaki vasculitis in infants and hypertension phenotype in rat model.

Authors:  Roch Listz Maurice; Nagib Dahdah; Johanne Tremblay
Journal:  Int J Vasc Med       Date:  2012-06-14

Review 9.  Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective.

Authors:  Nagib Dahdah; Anne Fournier
Journal:  Diagnostics (Basel)       Date:  2013-01-10

Review 10.  Pediatric Coronary Artery Revascularization Surgery: Development and Effects on Survival, Cardiac Events and Graft Patency for Children With Kawasaki Disease Coronary Involvements.

Authors:  Soichiro Kitamura
Journal:  Iran J Pediatr       Date:  2016-01-30       Impact factor: 0.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.